Home
About
Overview
Sharing Data
ORCID
Help
History (2)
First-In-Human Study of Cemiplimab Alone or In Combination with Radiotherapy and/or Low-dose Cyclophosphamide in Patients with Advanced Malignancies.
Molecular characterization may be of PARAMOUNT importance.
See All 2 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Molecular characterization may be of PARAMOUNT importance.
Dearing KR, Weiss GJ. Molecular characterization may be of PARAMOUNT importance. J Clin Oncol. 2014 Feb 10; 32(5):481-2.
View in:
PubMed
subject areas
Antimetabolites, Antineoplastic
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Non-Small-Cell Lung
Female
Glutamates
Guanine
Humans
Lung Neoplasms
Male
authors with profiles
Glen Weiss MD, MBA